| Financial Year |
September 30 2020 |
| Monetary Funds |
1,434,484,691.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
142,703,072.32 |
| Accounts Receivable |
658,817,632.09 |
| Advances to Suppliers |
50,866,053.87 |
| Other Receivables |
30,865,950.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
391,779,455.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,095,307.27 |
| Total Current Assets |
2,788,383,105.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
183,973,248.49 |
| Investment Properties |
32,261,483.66 |
| Fixed Assetes |
2,664,484,346.44 |
| Under-construction Projects |
88,213,880.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,290,753.12 |
| R&D expenses |
2,021,512.58 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,192,514.53 |
| Deferred Income Tax Assets |
49,690,229.49 |
| Other Non-Current Assets |
1,212,810.45 |
| Sub-Total of Non-Current Assets |
3,446,608,954.23 |
| Total Assets |
6,234,992,059.97 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
408,501,965.60 |
| Accounts Payable |
310,991,082.04 |
| Accounts Received In Advance |
2,785,306.52 |
| Employee Compensation Payable |
36,549,598.03 |
| Taxes Payable |
40,731,757.35 |
| Interest Payable |
-- |
| Dividend Payable |
1,960,000.00 |
| Other payables |
223,145,874.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,157,623,884.72 |
| Long-term Loans |
2,830,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,728,144.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
158,028,861.38 |
| Total Liabilities |
1,315,652,746.10 |
| Paid-In Capital(Or Share Stock) |
988,433,387.00 |
| Capital Surplus |
1,561,152,133.19 |
| Surplus Reserve |
294,354,266.14 |
| LESS:Treasury Stock |
131,905,146.40 |
| Undistributed Profits |
2,111,033,880.31 |
| Minority Stockholder's Interest |
96,270,793.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,823,068,520.24 |
| Owner's Equity（Stockholder's Equity） |
4,919,339,313.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,234,992,059.97 |
